Skip to main content

PARSONS CORP

For the period ended Mar 31, 2026. Filed Apr 29, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed Apr 29, 2026

PSN$51.49+5.3%Stored close · as of Nov 9, 2026

What changed in Risk Factors?

Read the current filing

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 19 previous paragraphs and 16 current paragraphs.

12 unchanged; 3 reworded; 1 added; 4 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

The current filing states there were no material changes to risk factors.

This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.

Current filing’s statement

There have been no material changes to our Risk Factors disclosed in the Company’s Form 10-K for the year ended December 31, 2025.
Added paragraphs (1)

Current report

During the three months ended March 31, 2026, none of our directors or officers adopted, modified or terminated any Rule 10b5-1 trading arrangement (as defined in Item 408(a) of Regulation S-K) or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K).
Removed paragraphs (4)

Previous report

Insider Trading Relationships and Policies

Previous report

In conformance with updated SEC regulations, the Company hasadopted amended insider trading policies and procedures governing the purchase, sale and/or other dispositions of the Company's securities by directors, officers and employees, or the Company itself, that are reasonably designed to promote compliance with insider trading laws, rules and regulations, and New York Stock Exchange standards.

Previous report

Executive Compensation

Previous report

As anticipated in the 8-K filed by Parsons Corporation on June 2, 2025, Parsons received notice of the termination for convenience of the material confidential contract with the Department of State on July 16, 2025. At the time of establishing the 2025 employee incentive plan, this termination was unforeseeable, and it was not within the control of the company nor its employees, having followed soon after the exercise of the contract option. Accordingly, the Parsons Board of Directors unanimously agreed that it is appropriate to modify certain 2025 short-term and long-term incentives for Parsons’ employees. Should the termination be revoked or the contract otherwise extended, any related financial benefit would be excluded from the incentive performance metrics.
Reworded paragraphs (3)

Previous wording

On August 9, 2021, the Company’s Board of Directors authorized the Company to acquire a number of shares of Common Stock having an aggregate market value of not greater than $100 million from time to time, commencing on August 12, 2021. The Board further amended this authorization in August 2022 to remove the prior expiration date and grant executive leadership the discretion to determine the price for such share repurchases. The Board further amended this authorization in March 2025 to increase and reset the repurchase capacity to $250 million. Any purchases made by the Company during Q1 of 2025 would be deducted from the reset capacity.

Current wording

On August 9, 2021, the Company’s Board of Directors authorized the Company to acquire a number of shares of Common Stock having an aggregate market value of not greater than $100 million from time to time, commencing on August 12, 2021. The Board further amended this authorization in August 2022 to remove the prior expiration date and grant executive leadership the discretion to determine the price for such share repurchases. The Board further amended this authorization in March 2025 to increase and reset the repurchase capacity to $250 million. Repurchases made by the Company during the first quarter of 2025 were deducted from the reset capacity.

Previous wording

As of September 30, 2025, the Company has spent $144.7 million repurchasing 2,679,421 shares of Common Stock at an average price of $54.00 per share.

Current wording

As of March 31, 2026, the Company has spent $239.7 million (which includes commissions paid of $79 thousand) repurchasing 4,119,224 shares of Common Stock at an average price of $58.19 per share.

Previous wording

1 Includes commissions in the calculation of average price per share

Current wording

Includes commissions in the calculation of average price per share.